Taro Pharm Company Profile

✉ Email this page to a colleague

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for TARO PHARM, and when can generic versions of TARO PHARM drugs launch?

TARO PHARM has sixty-one approved drugs.

There are seven US patents protecting TARO PHARM drugs. There are three tentative approvals on TARO PHARM drugs.

There are twenty patent family members on TARO PHARM drugs in nine countries and fifty-six supplementary protection certificates in fourteen countries.

Summary for Taro Pharm

International Patents:	20
US Patents:	7
Tradenames:	44
Ingredients:	42
NDAs:	61
Patent Litigation for Taro Pharm:	See patent lawsuits for Taro Pharm

Drugs and US Patents for Taro Pharm

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro Pharm Inds Ltd	ILOPERIDONE	iloperidone	TABLET;ORAL	207098-007	Jul 22, 2019		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Taro Pharm Inds Ltd	TOPICORT	desoximetasone	OINTMENT;TOPICAL	018594-001	Jan 17, 1985	AB	RX	Yes	Yes		See Plans and Pricing				See Plans and Pricing
Taro Pharms	CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE	betamethasone dipropionate; calcipotriene	SUSPENSION;TOPICAL	213269-001	Sep 2, 2020	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Taro Pharm Inds Ltd	HYDROCORTISONE	hydrocortisone	CREAM;TOPICAL	086155-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Taro Pharms Ireland	ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE	ondansetron hydrochloride	INJECTABLE;INJECTION	078014-001	Mar 21, 2008		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Taro Pharm Inds Ltd	ACETAMINOPHEN	acetaminophen	SUPPOSITORY;RECTAL	018337-002	Approved Prior to Jan 1, 1982		OTC	Yes	No		See Plans and Pricing				See Plans and Pricing
Taro Pharm Inds	CARBAMAZEPINE	carbamazepine	TABLET, CHEWABLE;ORAL	075687-001	Oct 24, 2000	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Taro Pharm

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Taro Pharms	PLIAGLIS	lidocaine; tetracaine	CREAM;TOPICAL	021717-001	Jun 29, 2006	5,919,479	See Plans and Pricing
Taro Pharms	TOPICORT	desoximetasone	SPRAY;TOPICAL	204141-001	Apr 11, 2013	5,990,100	See Plans and Pricing
Taro Pharms	PLIAGLIS	lidocaine; tetracaine	CREAM;TOPICAL	021717-001	Jun 29, 2006	6,528,086	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for TARO PHARM drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Topical Lotion	0.5%	➤ Subscribe	2011-03-16
➤ Subscribe	Topical Spray	0.25%	➤ Subscribe	2013-12-18

International Patents for Taro Pharm Drugs

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
China	101287374	See Plans and Pricing
China	102834096	See Plans and Pricing
Canada	2822220	See Plans and Pricing
European Patent Office	2523660	See Plans and Pricing
World Intellectual Property Organization (WIPO)	2007005988	See Plans and Pricing
World Intellectual Property Organization (WIPO)	2006130510	See Plans and Pricing
European Patent Office	1888026	See Plans and Pricing
>Country	>Patent Number	>Estimated Expiration

Supplementary Protection Certificates for Taro Pharm Drugs

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1519731	13C0067	France	See Plans and Pricing	PRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215
0463756	99C0007	Belgium	See Plans and Pricing	PRODUCT NAME: SILDENAFIL, NATL REGISTRATION NO/DATE: EU/1/98/077/001 19980914; FIRST REGISTRATION: CH 54642 19980622
2506844	1890025-8	Sweden	See Plans and Pricing	PRODUCT NAME: COMBINATION OF A PHARMACEUTICALLY ACCEPTABLE SALT OF UMECLIDINIUM (E.G. UMECLIDINIUM BROMIDE), VILANTEROL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEROF (E.G. VILANTEROL TRIFENATATE) AND FLUTICASONE FUROATE.; REG. NO/DATE: EU/1/17/1236 20171117
0152897	2001C/013	Belgium	See Plans and Pricing	PRODUCT NAME: DESLORATADINE; REGISTRTION NO/DATE: EU/1/00/160/010 20010115
0152897	SPC/GB01/012	United Kingdom	See Plans and Pricing	PRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115
1304992	PA2013025	Lithuania	See Plans and Pricing	PRODUCT NAME: CLINFAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
1519731	92269	Luxembourg	See Plans and Pricing	PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Time limited offer for new users ▶ Get up to 3 months free